BE891639A - Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine - Google Patents

Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine

Info

Publication number
BE891639A
BE891639A BE0/206948A BE206948A BE891639A BE 891639 A BE891639 A BE 891639A BE 0/206948 A BE0/206948 A BE 0/206948A BE 206948 A BE206948 A BE 206948A BE 891639 A BE891639 A BE 891639A
Authority
BE
Belgium
Prior art keywords
syndromas
butyro
betaine
caused
treatment
Prior art date
Application number
BE0/206948A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of BE891639A publication Critical patent/BE891639A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/206948A 1981-01-06 1981-12-28 Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine BE891639A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47518/81A IT1198434B (it) 1981-01-06 1981-01-06 Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina

Publications (1)

Publication Number Publication Date
BE891639A true BE891639A (fr) 1982-04-16

Family

ID=11260827

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/206948A BE891639A (fr) 1981-01-06 1981-12-28 Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine

Country Status (15)

Country Link
US (1) US4382092A (fr)
JP (1) JPS57136516A (fr)
AU (1) AU548787B2 (fr)
BE (1) BE891639A (fr)
CH (1) CH649218A5 (fr)
DE (1) DE3200016A1 (fr)
FR (1) FR2497510B1 (fr)
GB (1) GB2091101B (fr)
GR (1) GR75132B (fr)
IE (1) IE52404B1 (fr)
IL (1) IL64632A0 (fr)
IT (1) IT1198434B (fr)
LU (1) LU83869A1 (fr)
NL (1) NL8200022A (fr)
SE (1) SE453569B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US5030458A (en) * 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
IT1219448B (it) * 1988-02-12 1990-05-18 Sigma Tau Ind Farmaceuti Alimento per animali domestici carnivori, in particolare per cani integrato con l-carnitina
US5240961A (en) * 1992-07-02 1993-08-31 Shug Austin L Method of treating reduced insulin-like growth factor and bone loss associated with aging
US20030170290A1 (en) * 1993-06-16 2003-09-11 Shug Austin L. Delayed release carnitine
JP2553013B2 (ja) * 1993-07-19 1996-11-13 ヤマハ発動機株式会社 燃料噴射式エンジンの吸気装置
US5569457A (en) * 1994-11-18 1996-10-29 Shug; Austin L. Method of stimulating antibody formation
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
KR100411275B1 (ko) * 1999-09-15 2003-12-18 주식회사 포스코 언로더 코일 적치위치 제어장치
DE19956772A1 (de) * 1999-11-25 2001-06-07 Basf Ag Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
LV12979B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
DE3200016C2 (fr) 1992-12-03
JPS57136516A (en) 1982-08-23
US4382092A (en) 1983-05-03
LU83869A1 (fr) 1982-05-07
CH649218A5 (it) 1985-05-15
AU548787B2 (en) 1986-01-02
FR2497510B1 (fr) 1986-04-25
SE453569B (sv) 1988-02-15
GB2091101B (en) 1985-02-20
GB2091101A (en) 1982-07-28
IT1198434B (it) 1988-12-21
FR2497510A1 (fr) 1982-07-09
NL8200022A (nl) 1982-08-02
IL64632A0 (en) 1982-03-31
DE3200016A1 (de) 1982-08-12
JPH0424325B2 (fr) 1992-04-24
IE52404B1 (en) 1987-10-14
GR75132B (fr) 1984-07-13
SE8200007L (sv) 1982-07-07
AU7908781A (en) 1982-07-15
IE813099L (en) 1982-07-06
IT8147518A0 (it) 1981-01-06

Similar Documents

Publication Publication Date Title
BE890648A (fr) Compositions pour le traitement de l'acne
BE891639A (fr) Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine
MC1336A1 (fr) Procede pour la preparation de compositions pharmaceutiques
FR2578421B1 (fr) Compositions pharmaceutiques utiles pour le traitement des troubles de la memoire
FR2316954A1 (fr) Preparation dentaire pour le traitement de la parodontose
FR2333515A1 (fr) Compositions pharmaceutiques pour le traitement des troubles du metabolisme du calcium
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
FR2480603B1 (fr) Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
MA20655A1 (fr) Compositions pour le traitement de textiles
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
RO79428A2 (fr) Composition medicamenteuse pour le traitement des dermatoses
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
BE892781A (fr) Nouvelles compositions pharmaceutiques pour le traitement du diabete
BE812974A (fr) Compositions pharmaceutiques pour le traitement des ulceres
BE829024A (fr) Compositions pharmaceutiques pour le traitement de l'hydropisie
FR2517203B1 (fr) Composition pour le traitement de l'acne
PT79027A (fr) Procede de preparation de compositions pharmaceutiques contenant de la quinine
RO79211A2 (fr) Composition medicamenteuse pour le traitement de psoriazise
BE820360A (fr) Compositions pour le traitement de l'helminthiase
RO89432A2 (fr) Composition medicamenteuse pour le traitement du cancer
PT69341A (fr) Procede pour la preparation de compositions pharmaceutiques solides contenant gefarnate

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.

Effective date: 19941231